"
Team:Washington/Our Project
From 2014.igem.org
| Line 43: | Line 43: | ||
<h3> Components of the Degron Construct </h3> | <h3> Components of the Degron Construct </h3> | ||
| + | <img src="https://static.igem.org/mediawiki/2014/d/d9/Degron_construct.jpg" alt="Degron Constructs" style="width:500px;height:375px" align=center> | ||
| + | <p> Our experiment utilizes 5 different Degron constructs: <br> | ||
| + | -Deg0: This construct contains only the Gal4-VP16 transcriptional activator complex with the protein of interest in between the two (shortened as Gal4-Protein-VP16) <br> | ||
| + | -Deg1: This construct contains the Degron in front of our Gal4-Protein-VP16 complex. <br> | ||
| + | -Deg2: This construct contains the Degron in between Gal4 and the protein in our Gal4-Protein-VP15 complex. <br> | ||
| + | -Deg3: This construct contains the Degron in between the protein and VP16 in our Gal4-Protein-VP15 complex. <br> | ||
| + | -Deg4: This construct contains the Degron at the end of our Gal4-Protein-VP16 complex. <br> | ||
| + | </p> | ||
<h3> Test Protein </h3> | <h3> Test Protein </h3> | ||
Revision as of 03:06, 14 October 2014
|
|
Background
New novel methods must be first tested for viability against other existing methods. Our project is no different. In order, to gauge the effectiveness and accuracy of our method we choose test proteins that are well studied and characterized. Therefore, BINDI and several of its mutant variants that have been well studied were chosen. The first step of our project was to replicate the results of the studies on BINDI and its variants by repeating the stability test experiments presented in "the paper." After verifying the results of "the paper", we proceeded to construct our degron protein constructs and expressed them in yeast cells containing an inducible mechanism for the expression of green fluorescence protein. Subsequently, the fluorescent emission of each cell is measured as higher fluorescent corresponds to higher test protein stability.
Our System
Components of the Degron Construct
Our experiment utilizes 5 different Degron constructs:
-Deg0: This construct contains only the Gal4-VP16 transcriptional activator complex with the protein of interest in between the two (shortened as Gal4-Protein-VP16)
-Deg1: This construct contains the Degron in front of our Gal4-Protein-VP16 complex.
-Deg2: This construct contains the Degron in between Gal4 and the protein in our Gal4-Protein-VP15 complex.
-Deg3: This construct contains the Degron in between the protein and VP16 in our Gal4-Protein-VP15 complex.
-Deg4: This construct contains the Degron at the end of our Gal4-Protein-VP16 complex.
Test Protein
The test protein that must be chosen in testing a novel and new system must be a protein that has been well studied and rigorously examined through other existing and well established protein stability testing methods. Therefore,our team decided to use the protein known as BINDI.
Method
The essential process of our system involves cloning and manufacturing of a plasmid in E. coli . Once, the plasmids have been constructed and verified in E. coli they are transformed into S. cerevisiae. The plasmid constructs are then expressed. Following several days of growth the yeast cultures are passed through a Flow Cytometer and the fluorescence of each cell is measured. Higher fluorescence is associated with higher expression of the protein of interest which in-turn is indicative of higher protein stability.
Cloning in Escherichia coli
There are five possible degron constructs corresponding to five different positions the degron can take in our construct. The first step is to insert our protein into each of the five constructs and verify it.
Preparation and Passaging of Saccharomyces cerevisiae
Once, plasmids of the five possible degron constructs have been cloned with our three test proteins, they are subsequently transformed in PyE1 a strain of S. cerevisiae with the ability to produce green fluorescent proteins with the proper promoter protein such as Gal4 which is a part of our degron construct. Following the transformation, the cells are plated onto plates with on a Selective Dropout C-Uracil media and incubated at 30oC for 2 days. After two days, three colonies are chosen and added to an overnight culture of 3mL Selective Dropout Media C-Uracil and 2% Glucose then incubated for another two days at 30oC. After two days of incubation, a 20-50uL aliquot of each culture is "passaged" into another 3mL culture prepared in the same manner as before and incubated for the same duration and temperature as the previous culture. The passaging is done several times after each passage after the second passage, a glycerol stock is prepare from the culture and Flow Cytometry is run on the culture.
The purpose of passaging is to gradually remove excess copies of the plasmid constructs. Excess copies, exceeding one per cell will lead to multiple fold increase in the expression of the degron protein construct. As a result of this, GFP expression will also be increased thus reducing the viability and accuracy of the Flow Cytometry measurements conducted on each cell culture.
Relative Stability Analyzed via Flow Cytometry
Mutagenesis through Error Prone Polymerase Chain Reactions
Selecting Stable Variants through Fluorescence Activated Cell Sorting
Results
Protein stability analysis using Circular Dichroism
Our system was verified using Circular Dichroism (CD) analysis. A scan of the protein in solution in PBS was scanned across a variety of wavelengths to find the signal minima that would best indicate the state of folding. An equivalent concentration of protein in concentrated guanidinium chloride (GdmCL), a powerful chaotropic agent, was then prepared to be mixed in to our sample. This solution was then added to the sample in small increments, allowing us to measure the CD signal at increasing concentrations of GdmCl while maintaining a constant concentration of the protein being tested. The concentration of GdmCl at which the CD signal was half of its initial value was recorded. A higher concentration of GdmCl being required to half denature a protein indicates greater stability.
Protein expression analysis using SDS-PAGE
Samples of our protein of interest were taken at various points during the purification cycle. These samples were then run through gel electrophoresis to determine the relative amounts of protein produced by the cells. Larger bands were indicative of greater expression.
Protein stability analysis using Degron Constructs and Flow Cytometry
Mutagenesis Results and Mutant Variant Analysis
Future Plans
Examination of more proteins
Further evolving more stable variants of existing proteins
Submitted Parts
Degron (BBa_K1408000)
The Degron is an unstable protein domain that, when fused to a protein, acts as a source of instability. The presence of the Degron leads to degradation of the protein by the cell via ubiquitination. This is a new part we are submitting to the registry.
Gal4-VP16 Transcriptional Activator (BBa_K1408001)
This part consists of our Gal4-VP16 fusion protein, which is a transcriptional activator. Gal4 protein binds to a Gal1 promoter, while VP16 recruits transcription machinery, promoting transcription to anything under the Gal1 promoter. The two must be co-localized to work as a transcriptional activator.
This transcrptional activator has been previously submitted to the registry (BBa_K1179014 submitted by the iGEM 2013 MIT team). However, we noticed that this part was incomplete compared to ours and that this part had no user data related to it. In order to make the complete part available, together with experimental data related to the part, we decided to "re-submit" this part to the registry.
Gal4-Degron-VP16 (BBa_K1408002)
This part is a combination of our previous two parts submitted to the registry. By utilizing this system, the relative stabilities of proteins can be compared. A sequence for a protein inserted between the Degron and VP16 will produce a fusion protein which acts as a transcriptional activator for anything under a Gal1 promoter. If the protein inserted is unstable it will be degraded by the cell and the Gal4-VP16 transcriptional activator will no longer function. If a quantifiable marker protein such as Green Fluorescent Protein (GFP) is under Gal1 then the level of GFP output of the cell is related to the stability of the inserted protein.
